# A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate

> **NCT02884635** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 72 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** ASP1707
- **DRUG:** Placebo
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02884635
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-16
- **Primary completion:** 2017-10-18
- **Final completion:** 2017-10-25
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02884635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02884635, "A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02884635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*